title: Benign prostatic hyperplasia.
abstract: Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction and voiding symptoms in elderly men. The pathogenesis is not fully determined but a combination of androgens and age are needed for development of BPH. Symptoms of BPH are divided into obstructive and irritative symptoms but large interpersonal variability is found and no specific BPH symptom exists. Treatment modalities include surgery (TURP, TUIP, open prostatectomy, laser ablation, balloon dilatation, hyperthermia and thermotherapy, and urethral stents) and medical therapy. TURP is the gold standard treatment and TUIP is a safe and effective alternative to TURP in patients with smaller prostates. Laser ablation, hyperthermia and thermotherapy, and urethral stents are at the present time under investigation. Balloon dilatation is FDA-approved but not often used because of low efficacy and poor long-term results. Medical treatment includes alpha-blocker or finasteride treatment and is indicated in patients with moderate to severe symptoms of BPH without a strong indication for surgery.
authors.affiliation: Division of Urology, University of Wisconsin, Madison.
authors.forename: M
authors.initials: M
authors.lastname: Jonler
authors.forename: M
authors.initials: M
authors.lastname: Riehmann
authors.forename: R
authors.initials: R
authors.lastname: Brinkmann
authors.forename: R C
authors.initials: RC
authors.lastname: Bruskewitz
mesh_terms: D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy